Organ transplantation

Global Transplantation Market to 2027: Focus on Products (Tissue Products, Immunosuppressive Drugs), & Applications (Organ, Tissue Transplants)

Friday, September 25, 2020 - 5:30pm

Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period.

Key Points: 
  • Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period.
  • Thus, many biotechnology and medical device manufacturing companies are concentrating on the development of advanced transplant products.
  • Technological advancement in organ transplantation methods is another key factor supporting the market growth.
  • Introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.

CareDx Launches AlloCare at Virtual Transplant Festival

Thursday, September 24, 2020 - 12:00pm

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the launch of AlloCare at the CareDx organized AlloCare Transplant Festival on September 26, 2020.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the launch of AlloCare at the CareDx organized AlloCare Transplant Festival on September 26, 2020.
  • AlloCare will launch at the CareDx hosted AlloCare Transplant Festival, a virtual celebration to honor the organ transplant community and foster deeper connections among the extraordinary individuals and societies who are part of it.
  • The transplant community is extremely passionate and powerful, and Im honored to be participating in the AlloCare Transplant Festival, which also happens to coincide with my 21-year transplant anniversary, said Sean Elliott.
  • Over 25 transplant societies and advocacy organizations are coming together to support the AlloCare Transplant Festival, including the American Society of Transplantation (AST), the American Society of Transplant Surgeons (ASTS), the United Network for Organ Sharing (UNOS), Donate Life, the International Transplant Nurses Society (ITNS), and the Transplant Recipients International Organization (TRIO).

MissionGO Completes Longest Organ Delivery Flight via Unmanned Aircraft in Las Vegas

Tuesday, September 22, 2020 - 1:11pm

The second flight, which delivered a research kidney from an airport to a location outside of a small town in the Las Vegas desert, marked the longest organ delivery flight in UAS history.

Key Points: 
  • The second flight, which delivered a research kidney from an airport to a location outside of a small town in the Las Vegas desert, marked the longest organ delivery flight in UAS history.
  • The use of unmanned aircraft in a multimodal transportation chain will reduce the time between organ donation and transplantation, reduce the carbon footprint by using electric aircraft, and potentially expand organ procurement efficiency, saving more lives.
  • While MissionGO is focused on unmanned aircraft operations, its sister company MediGO is focused on improving organ transplant logistics across all modes of transportation.
  • By leveraging unmanned aircraft systems, MissionGO delivers improved reliability, reduced costs and increased transparency to benefit multiple sectors, including healthcare and retail.

Medeor Therapeutics’ Transplant Immune Tolerance Therapy Receives Regenerative Medicine Advanced Therapy Designation from FDA

Tuesday, September 22, 2020 - 12:00pm

Medeor Therapeutics, Inc. , a clinical-stage company dedicated to the development and commercialization of immunotherapies for transplantation, today announced that the U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to MDR-101, Medeors therapy designed to enable immune tolerance in kidney transplant patients, thereby eliminating the need for chronic immunosuppressive therapies.

Key Points: 
  • Medeor Therapeutics, Inc. , a clinical-stage company dedicated to the development and commercialization of immunotherapies for transplantation, today announced that the U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to MDR-101, Medeors therapy designed to enable immune tolerance in kidney transplant patients, thereby eliminating the need for chronic immunosuppressive therapies.
  • This important designation underscores the tremendous unmet medical need for alternatives to todays immunosuppressive therapies for transplantation, said Giovanni Ferrara, President and CEO of Medeor Therapeutics.
  • MDR-101 is being developed to avert transplant kidney rejection by the recipients immune system without the need for chronic use of immunosuppressive drugs.
  • The purpose of the current Phase 3 study is to demonstrate the efficacy and safety of MDR-101 for the induction of transplant immune tolerance in a prospective, randomized, multicenter clinical trial.

Global Transplantation Market Size, Share & Trends Analysis Report 2020-2027: Market Size is Expected to Reach USD 25.8 Billion - ResearchAndMarkets.com

Tuesday, September 22, 2020 - 10:55am

The "Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global transplantation market size is expected to reach USD 25.8 billion by 2027, growing at a CAGR of 9.3
    Growing cases of organ failure have resulted increased demand for transplantation procedures.
  • Rising demand for tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market growth during forecast period.
  • Technological advancement in organ transplantation methods is another key factor supporting the market growth.

Qihan Biotech Publishes First Clinical Xenotransplantation Prototype, ‘Pig 3.0’, in Nature Biomedical Engineering

Monday, September 21, 2020 - 4:15pm

The results, which were published today in Nature Biomedical Engineering, show enhanced immunocompatibility of xenogeneic organs and full eradication of porcine endogenous retroviruses (PERV).

Key Points: 
  • The results, which were published today in Nature Biomedical Engineering, show enhanced immunocompatibility of xenogeneic organs and full eradication of porcine endogenous retroviruses (PERV).
  • Qihan Biotech is committed to developing novel cell and organ therapies which can be available to patients worldwide.
  • Currently, the clinical applicability of allogeneic cell therapies and organ xenotransplantation is limited by molecular incompatibilities between the transplant and the recipient.
  • Qihan is also a pioneer in engineering extensively genome-modified pigs as bioreactors to grow xenogeneic cells, tissues and organs for safe and effective clinical applications.

BIOLIFE4D Names Pharmaceutical Veteran Kate Lewis as President

Monday, September 21, 2020 - 1:00pm

CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate Lewis as President of the company.

Key Points: 
  • CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate Lewis as President of the company.
  • Lewis brings more than 25 years of experience and relationships from within the pharmaceutical, transplantation, and regulatory industries.
  • Prior to BIOLIFE4D, she founded Nottingham Associates, a consulting firm focused on strategic client solutions for life science and pharmaceutical companies.
  • We are pleased to name Kate as both the first President and female executive of BIOLIFE4D.

National Kidney Foundation and Transplant Genomics Lace-Up for Kidney Patients

Friday, September 18, 2020 - 2:04pm

To help keep kidney patients, and those who care for them, safe during the national pandemic, this year's Kidney Walk has transitioned to a new, virtual format.

Key Points: 
  • To help keep kidney patients, and those who care for them, safe during the national pandemic, this year's Kidney Walk has transitioned to a new, virtual format.
  • "As a transplant patient, I can tell you organ rejection is a patient's greatest fear," said Kevin Longino, CEO and kidney transplant patient. "
  • COVID-19 has been particularly devastating to kidney transplant patients and support for our community is needed now more than ever before.
  • We're grateful to Transplant Genomics for their sponsorship of our Kidney Walk and for helping us continue with our mission to improve the lives of kidney patients nationwide."

Global Serological Transplant Diagnostics Market 2020-2027: U. S. Market is Estimated at $90.8 Million, While China is Forecast to Grow at 4.9% CAGR

Thursday, September 17, 2020 - 7:30pm

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The "Serological Transplant Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The "Serological Transplant Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Serological Transplant Diagnostics estimated at US$335.8 Million in the year 2020, is projected to reach a revised size of US$401.4 Million by 2027, growing at a CAGR of 2.6% over the period 2020-2027.
  • Reagents & Accessories, one of the segments analyzed in the report, is projected to record 2.8% CAGR and reach US$310.6 Million by the end of the analysis period.
  • The U. S. Market is Estimated at $90.8 Million, While China is Forecast to Grow at 4.9% CAGR
    The Serological Transplant Diagnostics market in the U. S. is estimated at US$90.8 Million in the year 2020.

UTHealth Surgeons at Memorial Hermann First in Texas to Perform Double Lung Transplant On Patient Whose Lungs Were Damaged By COVID-19

Thursday, September 17, 2020 - 12:18am

HOUSTON, Sept. 16, 2020 /PRNewswire/ --UTHealthtransplant surgeons at Memorial Hermann were the first in Texas to perform a double lung transplant on a 70-year-old man whose lungs were severely damaged by COVID-19.

Key Points: 
  • HOUSTON, Sept. 16, 2020 /PRNewswire/ --UTHealthtransplant surgeons at Memorial Hermann were the first in Texas to perform a double lung transplant on a 70-year-old man whose lungs were severely damaged by COVID-19.
  • "At that point, we determined that the only way he would survive was if he underwent a double lung transplant."
  • More than 2,700 lung transplants were performed in the United States in 2019 and approximately two-thirds of those were double lung transplants.
  • Jyothula said that patients survive longer when receiving a double lung transplant as opposed to a single lung transplant.